Aclaris Therapeutics Inc. (ACRS)
NASDAQ: ACRS
· Real-Time Price · USD
1.88
0.19 (11.24%)
At close: Aug 15, 2025, 3:59 PM
1.83
-2.40%
After-hours: Aug 15, 2025, 07:57 PM EDT
Aclaris Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.78M | 1.46M | 9.21M | 4.35M | 2.77M | 2.4M | 17.57M | 9.28M | 1.87M | 2.53M | 7.75M | 19.02M | 1.53M | 1.45M | 1.5M | 1.66M | 1.82M | 1.78M |
Cost of Revenue | 515K | 506K | 9.3M | 2.41M | 1.91M | 1.84M | 6.43M | 848K | 1.59M | 1.87M | 1.51M | 8.22M | 1.07M | 1.16M | 1.15M | 1.1M | 1.26M | 1.2M |
Gross Profit | 1.26M | 949K | -90K | 1.94M | 857K | 558K | 11.14M | 8.43M | 277K | 659K | 6.24M | 10.79M | 460K | 298K | 352K | 560K | 561K | 575K |
Operating Income | -18.41M | -18.08M | -99.67M | -10.47M | -12.85M | -13.63M | -4.05M | -31.58M | -31.82M | -30.72M | -21.98M | -18.67M | -24.39M | -20.11M | -22.89M | -20.3M | -18.01M | -28.53M |
Interest Income | 2.02M | 2.17M | 2.1M | 1.99M | 1.87M | 1.99M | n/a | 2.32M | n/a | n/a | n/a | 922K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -15.43M | -15.09M | -96.55M | -7.59M | -10.99M | -16.94M | -1.86M | -29.26M | -29.57M | -28.16M | -27.64M | -19.95M | -20.53M | -18.79M | -22.8M | -21.15M | -18.16M | -28.75M |
Net Income | -15.43M | -15.09M | -96.55M | -7.59M | -10.99M | -16.94M | -1.49M | -29.26M | -29.57M | -26.4M | -33.29M | -21.23M | -16.67M | -17.47M | -22.8M | -21.15M | -18.16M | -28.75M |
Selling & General & Admin | 5.39M | 6.14M | 4.95M | 5.65M | 4.65M | 4.34M | 8.21M | 7.09M | 8.32M | 8.79M | 7.15M | 5.81M | 6.08M | 6.1M | 6.94M | 5.98M | 5.87M | 4.83M |
Research & Development | 11.45M | 11.58M | 9.03M | 5.96M | 8.76M | 9.85M | 26.65M | 23.88M | 25.27M | 22.59M | 21.07M | 23.66M | 18.78M | 14.31M | 14.1M | 13.98M | 7.9M | 7.84M |
Other Expenses | 2.83M | 1.31M | 85.61M | 800K | 300K | n/a | -19.67M | 9.04M | n/a | n/a | n/a | n/a | n/a | 118K | 89K | n/a | n/a | n/a |
Operating Expenses | 19.67M | 19.03M | 99.58M | 12.41M | 13.71M | 14.19M | 15.19M | 40.01M | 33.59M | 31.38M | 28.22M | 29.47M | 24.85M | 20.41M | 21.05M | 19.95M | 13.77M | 12.66M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.91M | 2.2M | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -100K | -2.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.18M | 19.54M | 108.89M | 14.82M | 15.62M | 21.33M | 21.62M | 40.86M | 35.18M | 33.25M | 29.73M | 37.69M | 25.92M | 21.56M | 22.19M | 21.05M | 15.03M | 13.87M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -367K | n/a | n/a | -1.76M | 5.66M | 1.28M | -3.86M | -1.32M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 122.58M | 122.39M | 95.31M | 71.38M | 71.29M | 71.07M | 70.87M | 70.81M | 70.63M | 66.87M | 66.69M | 66.68M | 65.99M | 61.43M | 61.23M | 61.22M | 53.97M | 50.34M |
Shares Outstanding (Diluted) | 122.58M | 122.39M | 95.31M | 71.38M | 71.29M | 71.07M | 70.87M | 70.81M | 70.63M | 66.87M | 66.69M | 66.68M | 65.99M | 61.43M | 61.23M | 61.22M | 53.97M | 50.34M |
EPS (Basic) | -0.13 | -0.12 | -1.01 | -0.11 | -0.15 | -0.24 | -0.02 | -0.41 | -0.42 | -0.39 | -0.5 | -0.32 | -0.25 | -0.28 | -0.37 | -0.35 | -0.34 | -0.57 |
EPS (Diluted) | -0.13 | -0.12 | -1.01 | -0.11 | -0.15 | -0.24 | -0.02 | -0.41 | -0.42 | -0.39 | -0.5 | -0.32 | -0.25 | -0.28 | -0.37 | -0.35 | -0.34 | -0.57 |
EBITDA | -15.21M | -17.66M | -13.93M | -9.49M | -12.61M | -15.89M | -23.59M | -29.04M | -31.82M | -29.92M | -27.45M | -18.67M | -24.39M | -18.91M | -20.61M | -19.35M | -13.16M | -12.01M |
EBIT | -15.43M | -17.78M | -14.07M | -9.67M | -12.65M | -16.13M | -23.72M | -27.78M | -32.29M | -30.72M | -21.98M | -18.67M | -24.39M | -20.11M | -20.69M | -19.39M | -13.21M | -12.09M |
Depreciation & Amortization | 214K | 128K | 143K | 179K | 42K | 243K | 228K | 219K | 218K | 198K | 190K | 193K | 206K | 208K | 197K | 191K | 247K | 288K |